Molecule Name |
PE000591
|
Refractivity |
100
|
SMILES format |
[H][C@]1(CO)O[C@@]([H])(OC2=CC(O)=CC(\C=C\C3=CC=C(O)C=C3)=C2)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
|
Resonant Structures |
2
|
TPSA |
140
|
ASA hydrophobic |
349
|
ASA polar |
195
|
Accessible Surface Area |
543
|
LogS |
-3
|
MW |
390
|
cLogP |
1
|
H-Acceptors |
8
|
H-Donors |
6
|
Ro5 violations |
1
|
DrugScore |
0
|
Druglikeness |
-4
|
Irritant |
none
|
Mutagenic |
none
|
Reproductive Effective |
high
|
Tumorigenic |
none
|
Fish Toxicity |
High FHMT
|
Fish Toxicity 2 |
0.9814
|
Rat Acute Toxicity |
2
|
Acute Oral Toxicity |
III
|
Caco-2 Permeability |
Caco2-
|
Caco-2 Permeability 2 |
-1
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
CYP450 2C9 Substrate |
Non-substrate
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity 2 |
0
|
AMES Toxicity |
Non AMES toxic
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Ready biodegradable
|
Carcinogens |
Non-carcinogens
|
Blood-Brain Barrier |
BBB+
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
High HBT
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Carcinogenicity (Three-class) |
Non-required
|
Human Intestinal Absorption |
HIA-
|